MEET THE TEAM

Serge Maltais serves as President and CEO of Renaissance. Previously, Serge served as President and CEO of Héma-Québec, a governmental non-profit organization that manages the supply of blood, human tissues, cord blood, and maternal milk throughout the Province of Québec, Canada. Prior to that, Serge served as VP Supply Chain for Sandoz in Canada and held positions of increasing responsibility within Manufacturing and Operations at Baxter.

Serge holds a Bachelor of Industrial Engineering from École Polytechnique in Montréal, a Diploma in Business Administration from Université de Sherbrooke, and has completed the ICD-Rotman Directors Education Program (DEP), designed to build the competencies deemed necessary to be an effective board member.

Robert Harrer serves as the CFO of Renaissance. He has over 25 years of experience in financial management, with a strong operational focus in the specialty chemicals and pharmaceutical industry. Previously, he served as CFO at Avantor and Innophos, and held various financial leadership positions at Rohm and Haas. He also served on the Board of Directors of KMG Chemicals until the company was sold to Cabot Microelectronics.

Robert received his Master of Business Administration and Mathematics from Albert Einstein University in Ulm, Germany.

Julie Simon serves as the VP of Strategy and Business Development for Renaissance. She has over 15 years of management experience in the pharmaceutical industry, with a history of success in identifying & executing unique business opportunities, organizational transformation, and value creation. Julie previously held leadership positions with Ben Venue/Bedford Laboratories, Akorn, APP/Abraxis, Bioniche Pharma and Mylan. Her experience spans commercial, operational, and technical verticals, with a focus on Business Development, M&A, Commercial Operations, R&D, Strategic Sourcing and Quality.

Kimberly is a seasoned leader with over 20 years of experience in the pharmaceutical industry. She has deep experience in product development of all dosage forms with a specialty in preparing regulatory submissions, strategizing effective regulatory pathways, and developing innovative approaches. Before joining Renaissance, Kim worked at Impax Laboratories (via CorePharma acquisition) as the Senior Director, Regulatory Affairs. Prior to Impax she worked in roles of increasing responsibility at Dr. Reddy’s Laboratories, B. Braun Medical Inc, and Teva Pharmaceuticals.

Kim holds a B.S. in Chemistry from Cedar Crest College and an M.S. in Chemistry from Lehigh University.

Dan Brennan serves as the Vice President of Quality at Renaissance. Dan has over 30 years of pharmaceutical experience primarily with sterile injectable products. During these 30 years Dan has held positions of increasing responsibility in Laboratories, Quality Assurance and Manufacturing with Merck and Pfizer.

Dan holds a BS degree from Stockton State College, Pomona, NJ an MS from West Chester University, West Chester, PA and an MSc in Pharmaceutical Quality from the University of Strathclyde, Glasgow, Scotland.

Eric Kaneps serves as the VP of Sales & Marketing. Eric has over 25 years of experience in Sales, Business Development, and Account Management in the pharmaceutical industry.

Eric worked at DPT Laboratories as the Director of Business Development from 2001- 2016. In this role, he transitioned the OTC/Consumer Health based business toward Pharmaceutical based Nasal and Injectable Products which became the foundation for the new re-named entity-Renaissance Lakewood, LLC. In between his roles at the Lakewood site, Eric was Sr. VP of Business Development for Pharma-Tech Industries, a contract manufacturing organization that specializes in prescription and over-the-counter ingestible and topical products.

Eric holds a B.S. B.A. in International Business & Economics from The Ohio State University.

Al Atkinson serves as Vice President of Commercial Services and Supply Chain, leading the teams responsible for commercial account management, procurement, planning and scheduling, warehousing, and logistics. He has over 20 years of leadership experience in Pharmaceutical Manufacturing, Quality Systems, Program Management and Commercial Operations.

Prior to joining Renaissance, Al was Sr. Director of Development Services and Commercial Operations for DPT Laboratories, a Mylan company.

Al earned a Bachelor of Science degree in Biology from the University of Texas.

Jeff is the Vice President of Operations for Renaissance. He is responsible for all aspects of Manufacturing, MS&T, Engineering, Facilities & Maintenance, Strategic Initiatives and Operational Excellence. Jeff has over 27 years of experience in the pharmaceutical / medical device industry. Most recently, Jeff held the position of Site Head at Takeda. Prior to that, Jeff held roles of increasing responsibility at Baxter Healthcare including Senior Director Engineering/Strategic Initiatives, Director of Global Continuous Improvement, Plant Manager, Supply Chain Manager, Manufacturing Manager, and Project Engineer.

Jeff earned a Bachelor of Engineering degree in Mechanical Engineering at The University of Western Ontario and an MBA from The Schulich School of Business at York University.

Olutoyin (Toyin) Ojo is the Vice President of Human Resources for Renaissance. In this role she is responsible for the oversight of the Company’s Human Resources, Environmental Health & Safety and Security functions.

Toyin brings more than two decades of extensive HR experience across a variety of industries. Prior to joining Renaissance, Toyin served in a variety of HR Leadership roles at the following companies: Emerson, a global manufacturing and technology company; SGS, the World’s leading testing, inspection and certification company and Firmenich, the largest privately-owned perfume and taste business in its industry.

Toyin holds a bachelor’s degree in economics from City College, the City University of New York and a master’s in human resources management from Rutgers University.